Venture Capital

Updated:

Kamet Ventures

Kamet is a venture builder. We build companies that redefine systems in the field of healthtech, insurtech, and beyond.

Kamet Ventures logo

Kamet Ventures

Kamet is a venture builder. We build companies that redefine systems in the field of healthtech, insurtech, and beyond.

General information

Firm type

Venture Capital

Year founded

2016

AUM

Undisclosed

Location

Region

Europe

Country

France

City

Paris

Corporate office

30 Rue Fortuny, 75017 Paris, France

Additional offices

London, UK · Tel Aviv, Israel

Principals

Stephane Guinet

CEO and Founder

Michael Niddam

Co-founder and Managing Director

Nicolas Bosc

Co-founder and Managing Director

Sector focus

InsurTechDigital HealthMobility & TransportationPropTechFinancial Services

Frequently asked questions

How does Kamet Ventures source its portfolio companies?

Kamet does not source — it builds. The firm identifies unsolved problems in insurance, health, and mobility, then recruits a founder or operator and embeds them inside Kamet with a dedicated team, legal structure, and initial capital. This internal incubation runs for 12 to 24 months before the venture seeks external co-investors.

Is Kamet Ventures structured as a venture capital fund or a family office?

Neither. Kamet is a venture studio: it creates and operates new companies itself rather than buying equity in existing startups. It originated as AXA's corporate venturing arm in 2016 but has since separated into an independent entity that retains a balance sheet approach to capital allocation.

Does Kamet participate in follow-on rounds after the incubation period?

Kamet typically retains a founding equity stake in the ventures it launches and may participate in follow-on rounds selectively, but the studio model is designed to hand operational and fundraising leadership to the recruited CEO once the startup reaches commercial traction. The exact follow-on policy is not publicly disclosed.

What is Kamet's relationship with AXA today?

AXA provided the initial €100 million commitment and served as Kamet's sole backer at launch, but the studio has since operated independently. Kamet no longer functions as AXA's corporate venture arm, though historical ties remain; the firm now pursues deals and partnerships on their own commercial merits.

Which sectors does Kamet explicitly avoid?

Kamet concentrates on areas where regulation, underwriting, and legacy IT create durable moats. The firm has shown no public interest in consumer social platforms, pure SaaS enterprise tools without insurance or health exposure, or deep-tech hardware without an insurance or care-delivery angle.

How is Kamet's performance measured?

The absence of external LPs means Kamet does not report IRR or TVPI metrics publicly. Performance must be inferred from startup exits, subsequent institutional fundraises by portfolio companies, and the survival rate of incubated ventures — all of which the firm treats as private.

What is Kamet's known posture on co-investments alongside external VCs?

After the incubation window, Kamet actively brings in external VCs as co-investors to lead early-stage rounds and provide independent governance. The studio has syndicated with European fintech and insurtech specialists for companies including Anorak and Birdie.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Paris Venture Capital profiles